CoChat

Microbiota as a mediator of cancer progression and therapy

Open access
Pope, Jillian L., Tomkovich, Sarah, Yang, Ye, Jobin, Christian · 2017 · Translational Research
Cited by 79

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

&NA; Complex and intricate circuitries regulate cellular proliferation, survival, and growth, and alterations of this network through genetic and epigenetic events result in aberrant cellular behaviors, often leading to carcinogenesis. Although specific germline mutations have been recognized as cancer inducers, the vast majority of neoplastic changes in humans occur through environmental exposure, lifestyle, and diet. An emerging concept in cancer biology implicates the microbiota as a powerful environmental factor modulating the carcinogenic process. For example, the intestinal microbiota influences cancer development or therapeutic responses through specific activities (immune responses, metabolites, microbial structures, and toxins). The numerous effects of microbiota on carcinogenesis, ranging from promoting, preventing, or even influencing therapeutic outcomes, highlight the complex relationship between the biota and the host. In this review, we discuss the latest findings on this complex microbial interaction with the host and highlight potential mechanisms by which the microbiota mediates such a wide impact on carcinogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.trsl.2016.07.021

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 72

  1. Stratton, 2009, The cancer genome, Nature, 458, 719, 10.1038/nature07943 · DOI · Paper page
  2. Vogelstein, 2013, Cancer genome landscapes, Science, 339, 1546, 10.1126/science.1235122 · DOI · Paper page
  3. Garraway, 2013, Lessons from the cancer genome, Cell, 153, 17, 10.1016/j.cell.2013.03.002 · DOI · Paper page
  4. Anand, 2008, Cancer is a preventable disease that requires major lifestyle changes, Pharm Res, 25, 2097, 10.1007/s11095-008-9661-9 · DOI · Paper page
  5. Whiteside, 2015, The microbiome of the urinary tract–a role beyond infection, Nat Rev Urol, 12, 81, 10.1038/nrurol.2014.361 · DOI · Paper page
  6. Canny, 2008, Bacteria in the intestine, helpful residents or enemies from within?, Infect Immun, 76, 3360, 10.1128/IAI.00187-08 · DOI · Paper page
  7. Spor, 2011, Unravelling the effects of the environment and host genotype on the gut microbiome, Nat Rev Microbiol, 9, 279, 10.1038/nrmicro2540 · DOI · Paper page
  8. Fujimura, 2015, Microbiota in allergy and asthma and the emerging relationship with the gut microbiome, Cell Host Microbe, 17, 592, 10.1016/j.chom.2015.04.007 · DOI · Paper page
  9. Scher, 2011, The microbiome and rheumatoid arthritis, Nat Rev Rheumatol, 7, 569, 10.1038/nrrheum.2011.121 · DOI · Paper page
  10. Ussar, 2015, Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome, Cell Metab, 22, 516, 10.1016/j.cmet.2015.07.007 · DOI · Paper page
  11. Borges-Canha, 2015, Role of colonic microbiota in colorectal carcinogenesis: a systematic review, Rev Esp Enferm Dig, 107, 659, 10.17235/reed.2015.3830/2015 · DOI · Paper page
  12. De Martel, 2012, Global burden of cancers attributable to infections in 2008: a review and synthetic analysis, Lancet Oncol, 13, 607, 10.1016/S1470-2045(12)70137-7 · DOI · Paper page
  13. Jobin, 2013, Colorectal cancer: looking for answers in the microbiota, Cancer Discov, 3, 384, 10.1158/2159-8290.CD-13-0042 · DOI
  14. Gao, 2015, Microbiota disbiosis is associated with colorectal cancer, Front Microbiol, 6, 20, 10.3389/fmicb.2015.00020 · DOI · Paper page
  15. Narayanan, 2014, Human fecal microbiome-based biomarkers for colorectal cancer, Cancer Prev Res (Phila), 7, 1108, 10.1158/1940-6207.CAPR-14-0273 · DOI
  16. Pevsner-Fischer, 2016, Role of the microbiome in non-gastrointestinal cancers, World J Clin Oncol, 7, 200, 10.5306/wjco.v7.i2.200 · DOI
  17. Riley, 2013, Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples, PLoS Comput Biol, 9, e1003107, 10.1371/journal.pcbi.1003107 · DOI · Paper page
  18. Yamamoto, 2013, Intestinal bacteria modify lymphoma incidence and latency by affecting systemic inflammatory state, oxidative stress, and leukocyte genotoxicity, Cancer Res, 73, 4222, 10.1158/0008-5472.CAN-13-0022 · DOI
  19. Witkowska, 2013, Helicobacter pylori infection, chronic inflammation, and genomic transformations in gastric MALT lymphoma, Mediators Inflamm, 2013, 523170, 10.1155/2013/523170 · DOI
  20. Wotherspoon, 1993, Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori, Lancet, 342, 575, 10.1016/0140-6736(93)91409-F · DOI · Paper page
  21. Park, 2010, Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma, World J Gastroenterol, 16, 2158, 10.3748/wjg.v16.i17.2158 · DOI
  22. Zackular, 2013, The gut microbiome modulates colon tumorigenesis, MBio, 4, e00692, 10.1128/mBio.00692-13 · DOI · Paper page
  23. Son, 2015, Altered interactions between the gut microbiome and colonic mucosa precede polyposis in APCMin/+ mice, PLoS One, 10, e0127985, 10.1371/journal.pone.0127985 · DOI
  24. Zhan, 2013, Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury, Cancer Res, 73, 7199, 10.1158/0008-5472.CAN-13-0827 · DOI
  25. Dejea, 2014, Microbiota organization is a distinct feature of proximal colorectal cancers, Proc Natl Acad Sci U S A, 111, 18321, 10.1073/pnas.1406199111 · DOI · Paper page
  26. Johnson, 2015, Metabolism links bacterial biofilms and colon carcinogenesis, Cell Metab, 21, 891, 10.1016/j.cmet.2015.04.011 · DOI · Paper page
  27. Sesink, 1999, Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme, Cancer Res, 59, 5704
  28. Ijssennagger, 2015, Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon, Proc Natl Acad Sci U S A, 112, 10038, 10.1073/pnas.1507645112 · DOI · Paper page
  29. Louis, 2014, The gut microbiota, bacterial metabolites and colorectal cancer, Nat Rev Microbiol, 12, 661, 10.1038/nrmicro3344 · DOI · Paper page
  30. Matanoski, 2006, Demographics and tumor characteristics of colorectal cancers in the United States, 1998-2001, Cancer, 107, 1112, 10.1002/cncr.22008 · DOI
  31. Cao, 2014, The secondary bile acid, deoxycholate accelerates intestinal adenoma-adenocarcinoma sequence in Apc (min/+) mice through enhancing Wnt signaling, Fam Cancer, 13, 563, 10.1007/s10689-014-9742-3 · DOI
  32. Donohoe, 2014, A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner, Cancer Discov, 4, 1387, 10.1158/2159-8290.CD-14-0501 · DOI · Paper page
  33. Nicholson, 2012, Host-gut microbiota metabolic interactions, Science, 336, 1262, 10.1126/science.1223813 · DOI · Paper page
  34. Bindels, 2015, Non digestible oligosaccharides modulate the gut microbiota to control the development of leukemia and associated cachexia in mice, PLoS One, 10, e0131009, 10.1371/journal.pone.0131009 · DOI
  35. Kipanyula, 2013, Signaling pathways bridging microbial-triggered inflammation and cancer, Cell Signal, 25, 403, 10.1016/j.cellsig.2012.10.014 · DOI
  36. Davis, 2014, Emerging significance of NLRs in inflammatory bowel disease, Inflamm Bowel Dis, 20, 2412, 10.1097/MIB.0000000000000151 · DOI
  37. Vipperla, 2016, Diet, microbiota, and dysbiosis: a “recipe” for colorectal cancer, Food Funct, 7, 1731, 10.1039/C5FO01276G · DOI
  38. Cao, 2015, Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease, Nat Rev Immunol, 16, 35, 10.1038/nri.2015.8 · DOI · Paper page
  39. Van Der Kraak, 2015, Colitis-associated colon cancer: is it in your genes?, World J Gastroenterol, 21, 11688, 10.3748/wjg.v21.i41.11688 · DOI
  40. Liu, 2014, NOD2 polymorphisms associated with cancer risk: a meta-analysis, PLoS One, 9, e89340, 10.1371/journal.pone.0089340 · DOI
  41. Liu, 2015, Expression profile of innate immune receptors, NLRs and AIM2, in human colorectal cancer: correlation with cancer stages and inflammasome components, Oncotarget, 6, 33456, 10.18632/oncotarget.5587 · DOI
  42. Pédron, 2012, A crypt-specific core microbiota resides in the mouse colon, MBio, 3, 10.1128/mBio.00116-12 · DOI · Paper page
  43. Couturier-Maillard, 2013, NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer, J Clin Invest, 123, 700
  44. Alnabhani, 2016, Respective roles of hematopoietic and nonhematopoietic Nod2 on the gut microbiota and mucosal homeostasis, Inflamm Bowel Dis, 22, 763, 10.1097/MIB.0000000000000749 · DOI
  45. Robertson, 2013, Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis, Gut Microbes, 4, 222, 10.4161/gmic.24373 · DOI · Paper page
  46. Ayres, 2013, Inflammasome-microbiota interplay in host physiologies, Cell Host Microbe, 14, 491, 10.1016/j.chom.2013.10.013 · DOI
  47. Hu, 2013, Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer, Proc Natl Acad Sci U S A, 110, 9862, 10.1073/pnas.1307575110 · DOI · Paper page
  48. Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
  49. Man, 2015, The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection, Nat Immunol, 16, 467, 10.1038/ni.3118 · DOI · Paper page
  50. Meunier, 2015, Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with Francisella novicida, Nat Immunol, 16, 476, 10.1038/ni.3119 · DOI · Paper page
  51. Man, 2015, Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer, Cell, 162, 45, 10.1016/j.cell.2015.06.001 · DOI · Paper page
  52. Wilson, 2015, Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt, Nat Med, 21, 906, 10.1038/nm.3908 · DOI · Paper page
  53. West, 2015, Emerging cytokine networks in colorectal cancer, Nat Rev Immunol, 15, 615, 10.1038/nri3896 · DOI · Paper page
  54. Song, 2014, Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis, Immunity, 40, 140, 10.1016/j.immuni.2013.11.018 · DOI · Paper page
  55. Sundström, 2015, Human mucosa-associated invariant T cells accumulate in colon adenocarcinomas but produce reduced amounts of IFN-γ, J Immunol, 195, 3472, 10.4049/jimmunol.1500258 · DOI
  56. Ling, 2016, Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients, Sci Rep, 6, 20358, 10.1038/srep20358 · DOI · Paper page
  57. Lévy, 2015, Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth, Nat Cell Biol, 17, 1062, 10.1038/ncb3206 · DOI · Paper page
  58. Geis, 2015, Regulatory T-cell response to enterotoxigenic Bacteroides fragilis colonization triggers IL17-dependent colon carcinogenesis, Cancer Discov, 5, 1098, 10.1158/2159-8290.CD-15-0447 · DOI · Paper page
  59. DeStefano Shields, 2016, Reduction of murine colon tumorigenesis driven by enterotoxigenic Bacteroides fragilis using cefoxitin treatment, J Infect Dis, 214, 122, 10.1093/infdis/jiw069 · DOI
  60. Cuevas-Ramos, 2010, Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells, Proc Natl Acad Sci U S A, 107, 11537, 10.1073/pnas.1001261107 · DOI · Paper page
  61. Mousa, 2016, MATE transport of the E. coli-derived genotoxin colibactin, Nature Microbiology, 1, 15009, 10.1038/nmicrobiol.2015.9 · DOI
  62. Yang, 2014, Microbial imbalance and intestinal pathologies: connections and contributions, Dis Model Mech, 7, 1131, 10.1242/dmm.016428 · DOI · Paper page
  63. Mima, 2015, Fusobacterium nucleatum and T Cells in Colorectal Carcinoma, JAMA Oncol, 1, 653, 10.1001/jamaoncol.2015.1377 · DOI · Paper page
  64. Belcheva, 2015, Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?, Bioessays, 37, 403, 10.1002/bies.201400204 · DOI
  65. Ambalam, 2016, Probiotics, prebiotics and colorectal cancer prevention, Best Pract Res Clin Gastroenterol, 30, 119, 10.1016/j.bpg.2016.02.009 · DOI · Paper page
  66. Mori, 2003, Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer, Cancer Chemother Pharmacol, 51, 403, 10.1007/s00280-003-0585-0 · DOI
  67. Fittkau, 2004, Saccharic acid 1.4-lactone protects against CPT-11-induced mucosa damage in rats, J Cancer Res Clin Oncol, 130, 388, 10.1007/s00432-004-0557-8 · DOI
  68. Lin, 2014, The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats, PLoS One, 9, e83644, 10.1371/journal.pone.0083644 · DOI
  69. Paci, 2014, Review of therapeutic drug monitoring of anticancer drugs part 1–cytotoxics, Eur J Cancer, 50, 2010, 10.1016/j.ejca.2014.04.014 · DOI · Paper page
  70. Frank, 2015, TLR signaling modulates side effects of anticancer therapy in the small intestine, J Immunol, 194, 1983, 10.4049/jimmunol.1402481 · DOI · Paper page
  71. Sistigu, 2011, Immunomodulatory effects of cyclophosphamide and implementations for vaccine design, Semin Immunopathol, 33, 369, 10.1007/s00281-011-0245-0 · DOI · Paper page
  72. Iida, 2013, Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment, Science, 342, 967, 10.1126/science.1240527 · DOI · Paper page

Cited by

Metadata

Authors
Pope, J. L., Tomkovich, S., Yang, Y., & Jobin, C.
Venue
Translational Research
Publisher
Elsevier BV
Published
2017-01
Volume
179
Pages
139-154
ISSN
  • 1878-1810 (ISSN-L)
  • 1931-5244
OpenAlex
W2479524302
Cited by
79
References
49
FWCI
4.06
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
National Institutes of Health (RO1DK073338, RO1 AT08623)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.